Aelis Farma announced the reinforcement of its leadership team with the appointment of Arsène Guekam as Chief Corporate Development Officer. With over 15 years of experience in the Healthcare (biotech/medtech) and financial sectors, Arsène Guekam brings an unvaluable expertise to Aelis Farma in these fields. Graduate in Pharmacy and from the EM Lyon's Programme Grandes Ecoles (finance option), Arsène held key positions as a financial analyst in several renowned brokers such as Oddo BHF, CM-CIC Securities, or Crédit Lyonnais Small Caps.

Before joining Aelis Farma, Arsène served as Senior Analyst, Head of Biotech Research at Kepler Cheuvreux, and later as Co-Head of Healthcare Research. His extensive experience in financial markets and trend analysis, combined with a profound understanding of the challenges in the biotechnology industry, makes him an exceptional asset for Aelis Farma. As Chief Corporate Development Officer, Arsène will be responsible for steering and overseeing the Company?s development strategy, including identifying and evaluating new growth opportunities, fostering strategic partnerships, and strengthening relationships with investors.